FDA Warns Saintly Skin-Care Brand For Claims Transgressions
This article was originally published in The Rose Sheet
Harrington House’s Abbey St. Clare brand must atone for online skin-care claims that violate federal law per an FDA warning letter. The agency also recently posted a warning issued to Aloe Farms in July, the busiest month for cosmetic claims enforcement in FDA’s history.
You may also be interested in...
Add Menscience Androceuticals, La Bella Figura and Healing Scents to the list of skin-care marketers hit with FDA warning letters in July. The agency’s policy is to wait for warning letter recipients to acknowledge receipt before posting the communications to its website.
At least nine skin-care marketers received FDA warning letters in July for unapproved drug claims. In the month’s final two weeks, recipients included companies behind the Freeze 24-7 Instant Targeted Wrinkle Treatment and a Resurgent Stem Cell Firming Activator, among others.
Agency's updated FAQ web page tackles questions stakeholders have been asking in recent years about its Endorsement Guide, including the appropriate way to provide disclosures on social-media platforms and the responsibilities of companies using large networks of bloggers and other influencers to promote products.